| Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor AC Porter, JM Sauer, MD Knierman, GW Becker, MJ Berna, J Bao, ... Journal of Pharmacology and Experimental Therapeutics 301 (3), 1020-1024, 2002 | 830 | 2002 |
| Alterations in 5-HT1B Receptor Function by p11 in Depression-Like States P Svenningsson, K Chergui, I Rachleff, M Flajolet, X Zhang, ME Yacoubi, ... Science 311 (5757), 77-80, 2006 | 690 | 2006 |
| Systemic nicotine‐induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area M Nisell, GG Nomikos, TH Svensson Synapse 16 (1), 36-44, 1994 | 635 | 1994 |
| Sexual behavior enhances central dopamine transmission in the male rat JG Pfaus, G Damsma, GG Nomikos, DG Wenkstern, CD Blaha, ... Brain research 530 (2), 345-348, 1990 | 532 | 1990 |
| Diverse psychotomimetics act through a common signaling pathway P Svenningsson, ET Tzavara, R Carruthers, I Rachleff, S Wattler, M Nehls, ... Science 302 (5649), 1412-1415, 2003 | 365 | 2003 |
| Dopaminergic correlates of motivated behavior: importance of drive C Wilson, GG Nomikos, M Collu, HC Fibiger Journal of Neuroscience 15 (7), 5169-5178, 1995 | 359 | 1995 |
| Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations RR Edwards, RH Dworkin, DC Turk, MS Angst, R Dionne, R Freeman, ... Pain Reports 6 (1), e896, 2021 | 355 | 2021 |
| The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions ET Tzavara, RJ Davis, KW Perry, X Li, C Salhoff, FP Bymaster, JM Witkin, ... British journal of pharmacology 138 (4), 544-553, 2003 | 329 | 2003 |
| Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac) P Svenningsson, ET Tzavara, JM Witkin, AA Fienberg, GG Nomikos, ... Proceedings of the national academy of sciences 99 (5), 3182-3187, 2002 | 279 | 2002 |
| Nicotine and food induced dopamine release in the nucleus accumbens of the rat: putative role of α7 nicotinic receptors in the ventral tegmental area B Schilström, HM Svensson, TH Svensson, GG Nomikos Neuroscience 85 (4), 1005-1009, 1998 | 271 | 1998 |
| Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release M Nisell, GG Nomikos, TH Svensson Pharmacology & toxicology 75 (6), 348-352, 1994 | 267 | 1994 |
| N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens B Schilström, GG Nomikos, M Nisell, P Hertel, TH Svensson Neuroscience 82 (3), 781-789, 1997 | 262 | 1997 |
| Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat S Shirazi-Southall, DE Rodriguez, GG Nomikos Neuropsychopharmacology 26 (5), 583-594, 2002 | 240 | 2002 |
| The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone C Gras, B Amilhon, EM Lepicard, O Poirel, J Vinatier, M Herbin, S Dumas, ... Nature neuroscience 11 (3), 292-300, 2008 | 232 | 2008 |
| M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related … ET Tzavara, FP Bymaster, RJ Davis, MR Wade, KW Perry, J Wess, ... The FASEB journal 18 (12), 1410-1412, 2004 | 225 | 2004 |
| Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome BE Hildebrand, GG Nomikos, P Hertel, B Schilström, TH Svensson Brain research 779 (1-2), 214-225, 1998 | 225 | 1998 |
| Nicotine dependence, midbrain dopamine systems and psychiatric disorders M Nisell, GG Nomikos, TH Svensson Pharmacology & toxicology 76 (3), 157-162, 1995 | 225 | 1995 |
| Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and α1-adrenoreceptor antagonism TH Svensson, JM Mathe, JL Andersson, BG NOMIKOS, BE Hildebrand, ... Journal of clinical psychopharmacology 15 (1), 11S-18S, 1995 | 203 | 1995 |
| The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions P Svenningsson, GG Nomikos, BB Fredholm Journal of Neuroscience 19 (10), 4011-4022, 1999 | 202 | 1999 |
| The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons L Arborelius, K Chergui, S Murase, GG Nomikos, B Backlund Höök, ... Naunyn-Schmiedeberg's archives of pharmacology 347, 353-362, 1993 | 202 | 1993 |
George PanagisUniversity of Crete, Department of Psychology, University Campus at Gallos, Rethymno, Crete, GreeceVerifierad e-postadress på uoc.gr
